دورية أكاديمية

European lipodystrophy registry: background and structure.

التفاصيل البيبلوغرافية
العنوان: European lipodystrophy registry: background and structure.
المؤلفون: von Schnurbein, Julia, Adams, Claire, Akinci, Baris, Ceccarini, Giovanni, D'Apice, Maria Rosaria, Gambineri, Alessandra, Hennekam, Raoul CM, Jeru, Isabelle, Lattanzi, Giovanna, Miehle, Konstanze, Nagel, Gabriele, Novelli, Giuseppe, Santini, Ferruccio, Santos Silva, Ermelinda, Savage, David B, Sbraccia, Paolo, Schaaf, Jannik, Sorkina, Ekaterina, Tanteles, George, Vantyghem, Marie-Christine, Vatier, Camille, Vigouroux, Corinne, Vorona, Elena, Araújo-Vilar, David, Wabitsch, Martin
بيانات النشر: Springer Science and Business Media LLC
//dx.doi.org/10.1186/s13023-020-1295-y
Orphanet J Rare Dis
سنة النشر: 2020
المجموعة: Apollo - University of Cambridge Repository
مصطلحات موضوعية: Adipose tissue, Lipodystrophy, Rare diseases, Registry, Humans, Registries, Software
الوصف: BACKGROUND: Lipodystrophy syndromes comprise a group of extremely rare and heterogeneous diseases characterized by a selective loss of adipose tissue in the absence of nutritional deprivation or catabolic state. Because of the rarity of each lipodystrophy subform, research in this area is difficult and international co-operation mandatory. Therefore, in 2016, the European Consortium of Lipodystrophies (ECLip) decided to create a registry for patients with lipodystrophy. RESULTS: The registry was build using the information technology Open Source Registry System for Rare Diseases in the EU (OSSE), an open-source software and toolbox. Lipodystrophy specific data forms were developed based on current knowledge of typical signs and symptoms of lipodystrophy. The platform complies with the new General Data Protection Regulation (EU) 2016/679 by ensuring patient pseudonymization, informational separation of powers, secure data storage and security of communication, user authentication, person specific access to data, and recording of access granted to any data. Inclusion criteria are all patients with any form of lipodystrophy (with the exception of HIV-associated lipodystrophy). So far 246 patients from nine centres (Amsterdam, Bologna, Izmir, Leipzig, Münster, Moscow, Pisa, Santiago de Compostela, Ulm) have been recruited. With the help from the six centres on the brink of recruitment (Cambridge, Lille, Nicosia, Paris, Porto, Rome) this number is expected to double within the next one or 2 years. CONCLUSIONS: A European registry for all patients with lipodystrophy will provide a platform for improved research in the area of lipodystrophy. All physicians from Europe and neighbouring countries caring for patients with lipodystrophy are invited to participate in the ECLip Registry. STUDY REGISTRATION: ClinicalTrials.gov (NCT03553420). Registered 14 March 2018, retrospectively registered.
نوع الوثيقة: article in journal/newspaper
وصف الملف: Electronic; application/pdf
اللغة: English
العلاقة: https://www.repository.cam.ac.uk/handle/1810/303898Test
DOI: 10.17863/CAM.50982
الإتاحة: https://doi.org/10.17863/CAM.50982Test
https://www.repository.cam.ac.uk/handle/1810/303898Test
حقوق: Attribution 4.0 International ; https://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.18867444
قاعدة البيانات: BASE